ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 977

Conditional Deletion of MKL1 Inhibits Osteoclast Formation and Bone Erosions in Collagen Induced Arthritis Mice

Wenfeng Tan1, Aishu Luo 1, Yong Xu 2, Shiyu Lin 3, Miaojia Zhang 4 and Fang Wang 3, 1the First Affiliated Hospital of Nanjing Medical University, Nanjing, China (People's Republic), 2Nanjing Medical University, NANJING, China (People's Republic), 3the First Affiliated Hospital of Nanjing Medical University, Nanjing, 4the First Affiliated Hospital of Nanjing Medical University, Najing, China (People's Republic)

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: MKL1 and BONE EROSION, osteoclast, pathogenesis, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: RA – Animal Models Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Excessively osteoclasts (OCs) activation play an essential role in bone erosions in rheumatoid arthritis (RA). Thus, controlling OCs would be an effective strategy to prevent pathological bone resorption. OCs originate from the hematopoietic monocyte-macrophage lineage. We previously showed that MKL1 is high expressed in macrophages and is indispensable for TNFα induced proinflammatory transcription in macrophages. Here, we explored the effect of MKL1 on OCs differentiation and function and examined its role on bone resorption during inflammatory arthritis.

Methods: OCs differenation and function were assayed by TRAP staining and pit formation assay. Bone erosions in collagen induced arthritis mice (CIA) was analyzed by histopathology and MicroCT. RNA-seq was used to detect the potential mechanism that involved in OCs formation after conditional deletion of MKL1 in macrophages.

Results: The multinucleated osteoclast formation in vitro was impaired in bone marrow cells isolated from the KO mice compared with those from wild-type mice (WT). OCs related genes expression included TRAP and CTSK were significantly down-regulated in KO mice. Targeted ablation of MKL1 in macrophages resulted in decreased OCs numbers in bone marrow and increased bone mass in KO mice. In contrast, no effect on T cells, B cells and monocyte numbers in bone marrow.  Deletion of MKL1 mice showed the mild bone resorption after subcutaneously injecting of LPS on calvariae compared with WT mice. In a CIA model , KO mice exhibited the delayed arthritis onset, mild arthritis score, lower synovial inflammatory cell infiltration and decreased bone erosion, as compared with WT mice. RNA-seq indicated that OCs derived from mice with macrophage MKL1-deficient mice had an increased Rho kinase and IFN signaling pathway.

Conclusion: Our data suggested that MKL1 plays an important role in regulation osteoclast formation and bone erosions in CIA mice.


Disclosure: W. Tan, None; A. Luo, None; Y. Xu, None; S. Lin, None; M. Zhang, None; F. Wang, None.

To cite this abstract in AMA style:

Tan W, Luo A, Xu Y, Lin S, Zhang M, Wang F. Conditional Deletion of MKL1 Inhibits Osteoclast Formation and Bone Erosions in Collagen Induced Arthritis Mice [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/conditional-deletion-of-mkl1-inhibits-osteoclast-formation-and-bone-erosions-in-collagen-induced-arthritis-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/conditional-deletion-of-mkl1-inhibits-osteoclast-formation-and-bone-erosions-in-collagen-induced-arthritis-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology